Human Ciliary Neurotrophic Factor Uses, Dosage, Side Effects and more
Human Ciliary Neurotrophic Factor (NT-501) is Neurotech's lead product which is in two Phase II/III clinical trials for the treatment of visual loss associated with retinitis pigmentosa and a Phase II trial for the treatment of the dry form of age-related macular degeneration. Neurotech is also evaluating other factors that can be used with its proprietary delivery technology, Encapsulated Cell Technology (ECT), to treat additional retinal diseases.
| Attribute | Details |
|---|---|
| Trade Name | Human Ciliary Neurotrophic Factor |
| Generic | Ciliary neurotrophic factor |
| Ciliary neurotrophic factor Other Names | Ciliary neurotrophic factor (human), Human ciliary neurotrophic factor, Human CNTF |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in eye disorders/infections, macular degeneration, and retinal disorders (unspecified).
How Human Ciliary Neurotrophic Factor works
NT-501 is an intraocular, cell containing polymer implant designed to provide the continuous, long-term release of the therapeutic protein, Ciliary Neurotrophic Factor (CNTF), directly into the back of the eye by means of the Company's proprietary Encapsulated Cell Technology (ECT).
